Literature DB >> 19664140

Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis.

A Bayas1, M Stasiolek, N Kruse, K V Toyka, K Selmaj, R Gold.   

Abstract

Plasmacytoid dendritic cells (pDCs) are of crucial importance in immune regulation and response to microbial factors. In multiple sclerosis (MS), pDCs from peripheral blood showed an immature phenotype, but its role in susceptibility to MS is not determined. Because infectious diseases are established triggers of exacerbations in MS, in this study we have characterized the expression of Toll-like receptors (TLR) and the maturation and functional properties of peripheral blood pDCs from clinically stable, untreated MS patients in response to signals of innate immunity. After stimulation of TLR-9, interferon (IFN)-alpha production by pDCs was significantly lower in MS (n = 12) compared to healthy controls (n = 9). In an allogenic two-step co-culture assay we found an impaired effect of TLR-9 stimulation on IFN-gamma expression of autologous naive T cells in MS patients (n = 4). In peripheral blood mononuclear cells, TLR-9 stimulation with type A CpG ODN resulted in a higher expression of TLR-1, -2, -4, -5 and -8 in MS patients (n = 7) compared with healthy controls (n = 11). These findings suggest an altered innate immune response to microbial stimuli in MS patients and may help understanding of why common infectious agents trigger MS attacks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664140      PMCID: PMC2745026          DOI: 10.1111/j.1365-2249.2009.03964.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

Review 1.  Dendritic cells: immune regulators in health and disease.

Authors:  Mary F Lipscomb; Barbara J Masten
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

2.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

Authors:  M Cella; F Facchetti; A Lanzavecchia; M Colonna
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

3.  Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

Authors:  Sven Klaschik; Debra Tross; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

Review 4.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

5.  Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.

Authors:  S Rothenfusser; V Hornung; A Krug; A Towarowski; A M Krieg; S Endres; G Hartmann
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

6.  Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.

Authors:  B Pulendran; J Banchereau; S Burkeholder; E Kraus; E Guinet; C Chalouni; D Caron; C Maliszewski; J Davoust; J Fay; K Palucka
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

7.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS.

Authors:  Hakima Zekki; Douglas L Feinstein; Serge Rivest
Journal:  Brain Pathol       Date:  2002-07       Impact factor: 6.508

9.  Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2.

Authors:  C J Hertz; S M Kiertscher; P J Godowski; D A Bouis; M V Norgard; M D Roth; R L Modlin
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

10.  Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.

Authors:  Michel Gilliet; Yong-Jun Liu
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more
  10 in total

1.  Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta.

Authors:  Latt Latt Aung; Patricia Fitzgerald-Bocarsly; Suhayl Dhib-Jalbut; Konstantin Balashov
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

Review 2.  Dendritic cell control of tolerogenic responses.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

3.  Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.

Authors:  Siamak Sandoghchian Shotorbani; Zhao-Liang Su; Hua-Xi Xu
Journal:  World J Biol Chem       Date:  2011-07-26

4.  Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.

Authors:  Konstantin E Balashov; Latt Latt Aung; Adi Vaknin-Dembinsky; Suhayl Dhib-Jalbut; Howard L Weiner
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

5.  MicroRNAs and Multiple Sclerosis.

Authors:  Kemal Ugur Tufekci; Meryem Gulfem Oner; Sermin Genc; Kursad Genc
Journal:  Autoimmune Dis       Date:  2010-11-11

6.  Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse.

Authors:  Ana Leda F Longhini; Felipe von Glehn; Carlos Otávio Brandão; Rosemeire F O de Paula; Fernando Pradella; Adriel S Moraes; Alessandro S Farias; Elaine C Oliveira; Juan G Quispe-Cabanillas; Cassiana Horta Abreu; Alfredo Damasceno; Benito P Damasceno; Konstantin E Balashov; Leonilda M B Santos
Journal:  J Neuroinflammation       Date:  2011-01-07       Impact factor: 8.322

7.  Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.

Authors:  Valeria Allizond; Sara Scutera; Silvia Rossi; Tiziana Musso; Cristina Crocillà; Paola Cavalla; Claudia Trebini; Elisa Simona Marra; Anna Maria Cuffini; Giuliana Banche
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 8.  Immunomodulatory activity of interferon-beta.

Authors:  Lloyd H Kasper; Anthony T Reder
Journal:  Ann Clin Transl Neurol       Date:  2014-07-23       Impact factor: 4.511

Review 9.  Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems.

Authors:  Haixia Li; Shan Liu; Jinming Han; Shengxian Li; Xiaoyan Gao; Meng Wang; Jie Zhu; Tao Jin
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

10.  Distribution of subpopulations of dendritic cells in peripheral blood of patients treated with exogenous thyrotropin.

Authors:  Mariusz Stasiołek; Zbigniew Adamczewski; Bartosz Puła; Kinga Krawczyk-Rusiecka; Arkadiusz Zygmunt; Magdalena Borowiecka; Piotr Dzięgiel; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2012-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.